Cargando…
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
INTRODUCTION: Mammary-specific overexpression of Six1 in mice induces tumors that resemble human breast cancer, some having undergone epithelial to mesenchymal transition (EMT) and exhibiting stem/progenitor cell features. Six1 overexpression in human breast cancer cells promotes EMT and metastatic...
Autores principales: | Iwanaga, Ritsuko, Wang, Chu-An, Micalizzi, Douglas S, Harrell, J Chuck, Jedlicka, Paul, Sartorius, Carol A, Kabos, Peter, Farabaugh, Susan M, Bradford, Andrew P, Ford, Heide L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680936/ https://www.ncbi.nlm.nih.gov/pubmed/22765220 http://dx.doi.org/10.1186/bcr3219 |
Ejemplares similares
-
Eya2 Is Required to Mediate the Pro-Metastatic Functions of Six1 Via the Induction of TGF-β Signaling, Epithelial-Mesenchymal Transition, and Cancer Stem Cell Properties
por: Farabaugh, Susan M., et al.
Publicado: (2011) -
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3
por: Wang, Chu-An, et al.
Publicado: (2014) -
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
por: Smith, Anna L., et al.
Publicado: (2012) -
The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p
por: Towers, Christina G., et al.
Publicado: (2015) -
Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression
por: Micalizzi, Douglas S., et al.
Publicado: (2010)